Literature DB >> 7371851

Antigen-independent activation of the first component of complement C1 by chemically crosslinked rabbit IgG-oligomers.

J Tschopp, T Schulthess, J Engel, J C Jaton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7371851     DOI： 10.1016/0014-5793(80)80168-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  8 in total

1.  Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Authors:  Michael Huber; Viktor von Wyl; Christoph G Ammann; Herbert Kuster; Gabriela Stiegler; Hermann Katinger; Rainer Weber; Marek Fischer; Heribert Stoiber; Huldrych F Günthard; Alexandra Trkola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

2.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Assembly of subcomponents C1r and C1s of first component of complement: electron microscopic and ultracentrifugal studies.

Authors:  J Tschopp; W Villiger; H Fuchs; E Kilchherr; J Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

4.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

6.  C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.

Authors:  G Doekes; L A van Es; M R Daha
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

Review 7.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

Review 8.  IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development.

Authors:  Danlin Yang; Rachel Kroe-Barrett; Sanjaya Singh; Christopher J Roberts; Thomas M Laue
Journal:  MAbs       Date:  2017-08-16       Impact factor: 5.857
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.